F&O Call: Nandish Shah recommends to long Glenmark Pharma futures

The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.

Subscribe To Our Free Newsletter

All News, Business Standard All News